文献速递腹部技术与安全MR

基于对比增强MRI与病理图像的深度学习放射病理组学模型预测肝细胞癌血管包绕肿瘤簇及预后

Deep Learning Radiopathomics Models Based on Contrast-enhanced MRI and Pathologic Imaging for Predicting Vessels Encapsulating Tumor Clusters and Prognosis in Hepatocellular Carcinoma.
PubMed 文献 · Radiol Imaging Cancer · 2025-01-01

回顾性多中心研究纳入578例肝细胞癌患者,基于钆塞酸增强MRI和病理图像开发深度学习放射组学与病理组学模型预测血管包绕肿瘤簇(VETC),并构建放射病理组学列线图评估早期复发与无进展生存,外部测试集中VETC预测AUC为0.77~0.79。

要点

  • 基于钆塞酸增强MRI的深度学习放射组学模型在外部测试集预测VETC的AUC为0.77~0.79,病理组学模型AUC为0.79。
  • VETC阳性患者在所有数据集中深度学习放射组学评分及手工与深度学习病理组学评分均显著高于VETC阴性患者(均P<.001)。
  • 放射病理组学列线图整合动脉期深度学习放射组学评分及手工与深度学习病理组学评分,训练集、内部测试集、外部测试集预测3年PFS的时间依赖AUC分别为0.83、0.81、0.78。

核心结论

  • 深度学习放射病理组学模型有助于预测肝细胞癌VETC并评估早期复发与无进展生存风险。

研究设计与样本

  • 回顾性多中心研究,纳入578例肝细胞癌患者(平均年龄59岁±10;男442例,女136例),分为训练集317例、内部测试集137例、外部测试集124例,基于钆塞酸增强MRI和病理图像开发深度学习放射组学与病理组学模型预测VETC。

诊断标准与关键数值

  • 外部测试集中Swin Transformer预测VETC的深度学习放射组学模型AUC为0.77~0.79,病理组学模型AUC为0.79。
  • 放射病理组学列线图整合动脉期深度学习放射组学评分及手工与深度学习病理组学评分,训练集、内部测试集、外部测试集预测早期复发的C指数分别为0.69、0.60、0.67。
  • 同一列线图预测3年无进展生存的时间依赖AUC在训练集为0.83(95%CI:0.76,0.91),内部测试集为0.81(95%CI:0.68,0.94),外部测试集为0.78(95%CI:0.67,0.88)。

临床应用与阅片要点

  • 基于钆塞酸增强MRI的深度学习放射组学模型可用于预测肝细胞癌VETC状态,外部测试集AUC为0.77~0.79。
  • 放射病理组学列线图可对患者进行高、低风险分层,高风险与低风险患者的早期复发率和无进展生存率差异有统计学意义(均P<.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To develop deep learning (DL) radiopathomics models based on contrast-enhanced MRI and pathologic imaging to predict vessels encapsulating tumor clusters (VETC) and survival in hepatocellular carcinoma (HCC). Materials and Methods In this retrospective, multicenter study, 578 patients with HCC (mean age [±SD], 59 years ± 10; 442 male, 136 female) were divided into the training (n = 317), internal (n = 137), and external (n = 124) test sets. DL radiomics and pathomics models were developed to predict VETC using gadoxetic acid-enhanced MR and pathologic images. Deep radiomics score (DRS) and handcrafted and deep pathomics scores were compared between the group with VETC pattern in HCC (VETC+) and group without VETC pattern in HCC (VETC-). Multivariable Cox regression analyses were performed to identify independent prognostic factors, and the radiopathomics nomogram models were developed for early recurrence and progression-free survival (PFS). The prognostic power was evaluated using the concordance index (C index) and time-dependent receiver operating characteristic (ROC) curves. Results In the external test set, the Swin Transformer showed good performance for predicting VETC in both DL radiomics (area under the ROC curve [AUC], 0.77-0.79) and pathomics (AUC, 0.79) models. Patients with VETC+ HCC had significantly higher DRS and handcrafted and deep pathomics scores compared with patients with VETC- HCC in all datasets (all P < .001). The radiopathomics nomogram model incorporating DRS in the arterial phase and the handcrafted and deep pathomics scores achieved C indexes of 0.69, 0.60, and 0.67 for early recurrence and time-dependent AUCs of 0.83 (95% CI: 0.76, 0.91), 0.81 (95% CI: 0.68, 0.94), and 0.78 (95% CI: 0.67, 0.88) for 3-year PFS in the training, internal, and external test sets, respectively. Early recurrence and PFS rates statistically significantly differed between the high- and low-risk patients stratified by the radiopathomics nomogram model (all P < .05). Conclusion DL radiopathomics models effectively helped to predict VETC in HCC and assess the risk for early recurrence and PFS. Keywords: Hepatocellular Carcinoma, Deep Learning, MRI, Radiopathomics, Survival Supplemental material is available for this article. © RSNA, 2025.

来源:Radiol Imaging Cancer,查看原文。版权归原作者所有。

引用

  1. Yu Y, Cao L, Shen B, et al. Deep Learning Radiopathomics Models Based on Contrast-enhanced MRI and Pathologic Imaging for Predicting Vessels Encapsulating Tumor Clusters and Prognosis in Hepatocellular Carcinoma. Radiol Imaging Cancer. 2025. PMID: 40084948. doi:10.1148/rycan.240213

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。